The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure
Public ClinicalTrials.gov record NCT00082589. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Multi-Center,Study Evaluating the Effects of Eplerenone Versus Placebo on Ventricular Remodeling in Patient's With Left Ventricular Systolic Dysfunction (EF Less Than or Equal to 35%) and Mild to Moderate Heart Failure
Study identification
- NCT ID
- NCT00082589
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Industry
- Enrollment
- 250 participants
Conditions and interventions
Conditions
Interventions
- Eplerenone Drug
Drug
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2004
- Primary completion
- Not listed
- Completion
- Feb 28, 2006
- Last update posted
- Dec 21, 2020
2004 – 2006
United States locations
- U.S. sites
- 53
- U.S. states
- 25
- U.S. cities
- 45
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Castro Valley | California | 94546 | — |
| Pfizer Investigational Site | San Diego | California | 92103-8411 | — |
| Pfizer Investigational Site | Santa Rosa | California | 95403 | — |
| Pfizer Investigational Site | Walnut Creek | California | 94598-3084 | — |
| Pfizer Investigational Site | Denver | Colorado | 80262 | — |
| Pfizer Investigational Site | New Haven | Connecticut | 06510 | — |
| Pfizer Investigational Site | Fort Lauderdale | Florida | 33308 | — |
| Pfizer Investigational Site | Jacksonville | Florida | 32209 | — |
| Pfizer Investigational Site | Jacksonville | Florida | 32216 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30309-1721 | — |
| Pfizer Investigational Site | Augusta | Georgia | 30901 | — |
| Pfizer Investigational Site | Covington | Georgia | 30014 | — |
| Pfizer Investigational Site | Boise | Idaho | 83704-0107 | — |
| Pfizer Investigational Site | Bloomington | Illinois | 61701 | — |
| Pfizer Investigational Site | Normal | Illinois | 61761 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46202 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46260 | — |
| Pfizer Investigational Site | Auburn | Maine | 04210 | — |
| Pfizer Investigational Site | Ann Arbor | Michigan | 48105 | — |
| Pfizer Investigational Site | Detroit | Michigan | 48201 | — |
| Pfizer Investigational Site | Minneapolis | Minnesota | 55415 | — |
| Pfizer Investigational Site | Minneapolis | Minnesota | 55422 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63104 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63110-0250 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63110 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63117 | — |
| Pfizer Investigational Site | Lexington | Nebraska | 68850 | — |
| Pfizer Investigational Site | Lincoln | Nebraska | 68516 | — |
| Pfizer Investigational Site | McCook | Nebraska | 69001 | — |
| Pfizer Investigational Site | Lebanon | New Hampshire | 03756 | — |
| Pfizer Investigational Site | Albany | New York | 12205 | — |
| Pfizer Investigational Site | Manhasset | New York | 11030 | — |
| Pfizer Investigational Site | New York | New York | 10032 | — |
| Pfizer Investigational Site | West Islip | New York | 11795 | — |
| Pfizer Investigational Site | Mount Airy | North Carolina | 27030 | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27109 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45219 | — |
| Pfizer Investigational Site | Lorain | Ohio | 44053 | — |
| Pfizer Investigational Site | Sandusky | Ohio | 44870-3390 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73120 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19107 | — |
| Pfizer Investigational Site | Sayre | Pennsylvania | 18840 | — |
| Pfizer Investigational Site | Pawtucket | Rhode Island | 02860 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29401 | — |
| Pfizer Investigational Site | Germantown | Tennessee | 38138 | — |
| Pfizer Investigational Site | Nashville | Tennessee | 37212 | — |
| Pfizer Investigational Site | Beaumont | Texas | 77630 | — |
| Pfizer Investigational Site | Beaumont | Texas | 77702 | — |
| Pfizer Investigational Site | Houston | Texas | 77030 | — |
| Pfizer Investigational Site | Galax | Virginia | 24333 | — |
| Pfizer Investigational Site | Roanoke | Virginia | 24014 | — |
| Pfizer Investigational Site | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00082589, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 21, 2020 · Synced May 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00082589 live on ClinicalTrials.gov.